US 10294474
Targeting ligands
granted A61KA61K31/7008A61K31/7105
Quick answer
US patent 10294474 (Targeting ligands) held by Arrowhead Pharmaceuticals, Inc. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 50
- CPC classes
- A61K, A61K31/7008, A61K31/7105, A61K31/711, A61K31/713